CureVac's COVID-19 vaccine triggers immune response in Phase I trial - Reuters

Reuters | Nov. 2, 2020, 7:13 a.m. | Original
CureVac's COVID-19 vaccine triggers immune response in Phase I trial Reuters
Italy to tighten COVID curbs, but holds back from lockdown - Reuters Israeli settlers pray for Trump re-election at biblical tomb - Reuters